Material Detail

"Eli Lilly: Recreating Drug Discovery for the 21st Century" icon

Eli Lilly: Recreating Drug Discovery for the 21st Century

This case "describes changes facing the structure of the pharmaceutical industry as a result of new science and untenable cost structures and Eli Lilly's long-range strategy involving the development of tailored drugs." The case is a "follow on case to 'Lilly’s Project Resilience,' although it can also be taught as a stand alone case. Designed to explore the issues inherent in trying to implement a significantly different strategy without investing in significant organizational change. Explores the choices Lilly has made to invest in 'tailored therapeutics' and asks the students to consider whether they will lead to success."


More about this material


Log in to participate in the discussions or sign up if you are not already a MERLOT member.